Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Janssen Pharmaceuticals to pay over $1.6 billion in drug misbranding case

On behalf of the U.S. Food and Drug Administration, the U.S. Department of Justice today announced a guilty plea agreement with Janssen Pharmaceuticals, Inc., of Titusville, N.J., and a $400 million criminal fine for introducing a misbranded drug, Risperdal (risperidone), into interstate commerce.

5 Nov 2013

Magnesium deficiency may play important role in cognitive impairment

November is National Alzheimer's Awareness Month and the serious issues of cognitive health will be in the spotlight in the coming weeks. The medical community agrees that cognitive impairment, ranging from mild to severe, is almost epidemic in the U.S. as the Baby Boomer generation is aging and living longer. Scientists believe one reason is that the human brain begins shrinking after age 25. Structural changes and loss of brain synapses lead to rapid decline in cognitive health.

5 Nov 2013

SRI to expand current preclinical molecular imaging capabilities with MILabs VECTor+ system

MILabs is pleased to announce that Sunnybrook Research Institute, the research arm of the Sunnybrook Health Sciences Centre, located in Toronto, Canada will install a MILabs VECTor+ system to expand their current preclinical molecular imaging capabilities.

4 Nov 2013

Discovery may lead to curing of Alzheimer's and Parkinson's disease via photo therapy

Researchers at Chalmers University of Technology in Sweden, together with researchers at the Polish Wroclaw University of Technology, have made a discovery that may lead to the curing of diseases such as Alzheimer's, Parkinson's and Creutzfeldt-Jakob disease (the so called mad cow disease) through photo therapy.

3 Nov 2013

Scientists identify new toxic entity associated with dementia and motor neuron disease

A new toxic entity associated with genetically inherited forms of dementia and motor neuron disease has been identified by scientists at the UCL Institute of Neurology. The toxin is the result of a genetic mutation that leads to the production of RNA molecules which could be responsible for the diseases. The findings are published in the journal Acta Neuropathologica.

31 Oct 2013

S14G-humanin: New effective treatment for Alzheimer's disease

Humanin is a potential therapeutic agent for Alzheimer's disease, and its derivative, S14G-humanin, is 1 000-fold stronger in its neuroprotective effect against Alzheimer's disease-relevant insults. Al-though effective, the detailed molecular mechanism through which S14G-humanin exerts its effects remains unclear.

31 Oct 2013

Reduced SMG1 protein expression may contribute to neurological disorders

The absence of a protein called SMG1 could be a contributing factor in the development of Parkinson's disease and other related neurological disorders, according to a study led by the Translational Genomics Research Institute.

31 Oct 2013

New DNA vaccine effective against plaques in mouse model of Alzheimer's disease

Amyloid-beta (Aβ) active immunization in Alzheimer's disease can increase the rate of Aβ clearance, and delay cognitive dysfunction, but it is easy to induce meningoencephalitis, which may be related to activation of Th1 lymphocytes.

30 Oct 2013

Video gaming increases spatial orientation, memory formation and motor skills

Video gaming causes increases in the brain regions responsible for spatial orientation, memory formation and strategic planning as well as fine motor skills.

30 Oct 2013

Alzheimer's patients more prone to heart disease, but undergo fewer related surgeries

Persons with Alzheimer's disease suffer from ischaemic heart diseases more frequently than others, yet they undergo related procedures and surgery less frequently than persons with no diagnosed AD, according to a nation-wide register-based study carried out at the University of Eastern Finland.

30 Oct 2013

New Dementia Service Center established as pilot project

In Germany, approximately 1.3 million people currently suffer from dementia. About 250,000 incident cases are estimated per year. Dementia is the leading cause of dependency and disability among older persons.

30 Oct 2013

Study: Glucose levels, vascular damage contribute to dementia

High blood-sugar levels, such as those linked with Type 2 diabetes, make beta amyloid protein associated with Alzheimer's disease dramatically more toxic to cells lining blood vessels in the brain, according to a new Tulane University study published in latest issue of the Journal of Alzheimer's Disease.

29 Oct 2013

Study shows how wrong levels of protein linked with AD can lead to dangerous blockages in brain cells

Scientists have known for some time that a protein called presenilin plays a role in Alzheimer's disease, and a new study reveals one intriguing way this happens.

29 Oct 2013

International researchers identify 11 new genes linked to Alzheimer's disease

An international group of researchers has identified 11 new genes that offer important new insights into the disease pathways involved in Alzheimer's disease. The highly collaborative effort involved scanning the DNA of over 74,000 volunteers-the largest genetic analysis yet conducted in Alzheimer's research-to discover new genetic risk factors linked to late-onset Alzheimer's disease, the most common form of the disorder.

28 Oct 2013

UL research aims to improve diagnosis and management of delirium among palliative care patients

University of Limerick researchers have been awarded €175,000 to undertake research which aims to improve diagnosis and management of delirium, dementia and depression among palliative care patients.

28 Oct 2013

NHMRC awards over $6M for Griffith University research projects

Griffith University research projects have been awarded just over $6m in research funding by the prestigious National Health and Medical Research Council.

28 Oct 2013

Plant Sterols prove to be better cholesterol in Alzheimer`s disease

"Plant sterols are present in various combinations in nuts, seeds and plant oils. As plant sterols are the equivalents of animal cholesterol, they can in principal influence metabolic processes, where cholesterol is involved," explained Marcus Grimm, Head of the Experimental Neurology Laboratory at Saarland University. "Because they also lower cholesterol levels, they are extensively used in the food industry and as dietary supplements."

25 Oct 2013

OPTIMISTIC study aims to reduce avoidable hospitalizations, increase access to palliative care

The OPTIMISTIC study, an innovative initiative developed by research-clinicians from Indiana University and the Regenstrief Institute to improve health care, reduce avoidable hospitalizations and increase access to palliative care, is now underway in 19 nursing facilities throughout Central Indiana.

25 Oct 2013

Canadian Partnership Against Cancer, Heart and Stroke Foundation to improve health of Canadians

The Canadian Partnership Against Cancer and the Heart and Stroke Foundation, are pleased to announce a $16 million investment in a first of its kind partnership between the cancer and cardiovascular research communities that will strengthen our understanding of chronic disease.

24 Oct 2013

Study shows plant sterols appear to prevent onset of Alzheimer's disease

It's no secret that many of the phytochemicals in fruit and vegetables have a positive effect on our health. For instance, plant sterols (also known as phytosterols) help to lower cholesterol levels. According to a new study by researchers at Saarland University, they also appear to prevent the onset of Alzheimer's disease.

24 Oct 2013

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Janssen Pharmaceuticals to pay over $1.6 billion in drug misbranding case

Magnesium deficiency may play important role in cognitive impairment

SRI to expand current preclinical molecular imaging capabilities with MILabs VECTor+ system

Discovery may lead to curing of Alzheimer's and Parkinson's disease via photo therapy

Scientists identify new toxic entity associated with dementia and motor neuron disease

S14G-humanin: New effective treatment for Alzheimer's disease

Reduced SMG1 protein expression may contribute to neurological disorders

New DNA vaccine effective against plaques in mouse model of Alzheimer's disease

Video gaming increases spatial orientation, memory formation and motor skills

Alzheimer's patients more prone to heart disease, but undergo fewer related surgeries

New Dementia Service Center established as pilot project

Study: Glucose levels, vascular damage contribute to dementia

Study shows how wrong levels of protein linked with AD can lead to dangerous blockages in brain cells

International researchers identify 11 new genes linked to Alzheimer's disease

UL research aims to improve diagnosis and management of delirium among palliative care patients

NHMRC awards over $6M for Griffith University research projects

Plant Sterols prove to be better cholesterol in Alzheimer`s disease

OPTIMISTIC study aims to reduce avoidable hospitalizations, increase access to palliative care

Canadian Partnership Against Cancer, Heart and Stroke Foundation to improve health of Canadians

Study shows plant sterols appear to prevent onset of Alzheimer's disease

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Newsletters you may be interested in